{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:18:12Z","timestamp":1761535092145,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":2411,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1111\/jth.13299","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T08:10:37Z","timestamp":1456560637000},"page":"936-939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Polyvinylpyrrolidone induced artefactual prolongation of activated partial thromboplastin times in intravenous drug users with renal failure"],"prefix":"10.1016","volume":"14","author":[{"given":"A.H.","family":"Kristoffersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.K.","family":"Bj\u00e5nes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jordal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Leh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Leh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Svarstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13299_bb0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2141.2007.06968.x","article-title":"Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology","volume":"140","author":"Chee","year":"2008","journal-title":"Br J Haematol"},{"issue":"Suppl. 3","key":"10.1111\/jth.13299_bb0015","first-page":"452","article-title":"An unusual cause of renal insufficiency: polyvinylpyrrolidone storage in opioid addicted patients","volume":"29","author":"Leh","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jth.13299_bb0020","unstructured":"B\u00fchler V. Kollidon. .Polyvinylpyrrolidone excipients for the pharmaceutical industry, 9th revised edition. 2008. http:\/\/www.pharma-ingredients.basf.com\/Documents\/ENP\/Brochure\/EN\/G-EMPMD256_Kollidon_Polyvinylpyrrolidone_excipients_for_the_pharmaceutical_industry.pdf. Accessed 31 May 2013."},{"key":"10.1111\/jth.13299_bb0025","unstructured":"European Medicines Agency, Science Medicines Health, Annual Report 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2014\/07\/WC500170053.pdf, 2014."},{"key":"10.1111\/jth.13299_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2009.09.001","article-title":"Lupus anticoagulant (LAC) testing in patients with inflammatory status: does C\u2010reactive protein interfere with LAC test results?","volume":"125","author":"Schouwers","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13299_bb0035","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2141.2011.08990.x","article-title":"False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: interference of C\u2010reactive protein","volume":"157","author":"van Rossum","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13299_bb0040","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1515\/cclm-2014-0906","article-title":"Interference of C\u2010reactive protein with clotting times","volume":"53","author":"Devreese","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.13299_bb0045","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/MBC.0000000000000176","article-title":"Artifactual prolongation of activated partial thromboplastin time with PEGylated compounds in silica\u2010based assays","volume":"25","author":"Murphy","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13299_bb0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/hae.12374","article-title":"Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94\u20109027) for haemophilia A","volume":"20","author":"Gu","year":"2014","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13299","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13299","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13299\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:14:11Z","timestamp":1761534851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622035115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1538783622035115"],"URL":"https:\/\/doi.org\/10.1111\/jth.13299","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyvinylpyrrolidone induced artefactual prolongation of activated partial thromboplastin times in intravenous drug users with renal failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}